Orthocell Limited Dividend 2022

Orthocell Limited (OCC) is engaged in the development and commercialization of novel collagen medical devices and cellular therapies for the repair and regeneration of human tendons, bone, nerve and cartilage defects. It has a Good Manufacturing Process (GMP) facility in place for quality control and also holds an ISO certification for the manufacture of its products such as CelGro. The company’s predominant place of operation is in Australia.

Orthocell Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.orthocell.com.au.

You can also check out dividend history for similar stocks in the same sector as follows:

OCC Dividend Dates

Please click the table header to sort the data.

No Dividend Dates Found